Literature DB >> 2786367

The time course of steroid action on blood-to-brain and blood-to-tumor transport of 82Rb: a positron emission tomographic study.

J O Jarden1, V Dhawan, J R Moeller, S C Strother, D A Rottenberg.   

Abstract

Blood-to-brain and blood-to-tumor transport rate constants for Rb (K1) and apparent tissue blood volume (Vb) were estimated in 8 patients with primary or metastatic brain tumors before and approximately 6 hours after a 100-mg intravenous bolus injection of dexamethasone using 82Rb and positron emission tomography. Eight additional patients were studied to evaluate test-retest variability and repositioning errors. Six hours following dexamethasone administration tumor K1 (but not Vb) was significantly reduced compared with contralateral control brain regions (p less than 0.03). These data are consistent with our previously published 24-hour-postdexamethasone data and suggest that comparable effects of corticosteroids on brain/tumor capillaries may be observed at 5 to 6 and 24 hours. The time course of dexamethasone-induced alterations in brain/tumor capillary permeability supports the view that these alterations may be responsible for at least some of the antiedema effects of corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786367     DOI: 10.1002/ana.410250306

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Therapeutic implications of tumor interstitial fluid pressure in subcutaneous RG-2 tumors.

Authors:  Yot Navalitloha; Erica S Schwartz; Elizabeth N Groothuis; Cathleen V Allen; Robert M Levy; Dennis R Groothuis
Journal:  Neuro Oncol       Date:  2006-06-14       Impact factor: 12.300

2.  The effect of steroid on thallium-201 uptake by malignant gliomas.

Authors:  H Namba; T Togawa; N Yui; M Yanagisawa; F Kinoshita; Y Iwadate; K Ohsato; K Sueyoshi
Journal:  Eur J Nucl Med       Date:  1996-08

3.  Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.

Authors:  J D Heiss; E Papavassiliou; M J Merrill; L Nieman; J J Knightly; S Walbridge; N A Edwards; E H Oldfield
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

4.  In vivo CT measurement of blood-brain transfer constant of iopamidol in human brain tumors.

Authors:  W T Yeung; T Y Lee; R F Del Maestro; R Kozak; T Brown
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

5.  Factors affecting perceived tumor volumes in magnetic resonance imaging.

Authors:  R L Galloway; R J Maciunas; A L Failinger
Journal:  Ann Biomed Eng       Date:  1993 Jul-Aug       Impact factor: 3.934

6.  The effects of dexamethasone on transcapillary transport in experimental brain tumors: II. Canine brain tumors.

Authors:  P C Warnke; P Molnar; G D Lapin; A Kuruvilla; D R Groothuis
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  The effects of dexamethasone on experimental brain tumors: I. Transcapillary transport and blood flow in RG-2 rat gliomas.

Authors:  P Molnar; G D Lapin; D R Groothuis
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

8.  Effect of steroids on iopamidol blood-brain transfer constant and plasma volume in brain tumors measured with X-ray computed tomography.

Authors:  W T Yeung; T Y Lee; R F Del Maestro; R Kozak; J Bennett; T Brown
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Contrast Leakage Patterns from Dynamic Susceptibility Contrast Perfusion MRI in the Grading of Primary Pediatric Brain Tumors.

Authors:  C Y Ho; J S Cardinal; A P Kamer; C Lin; S F Kralik
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

Review 10.  Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.

Authors:  R D Fross; P C Warnke; D R Groothuis
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.